UBI Ubisoft Entertainment SA

Ubisoft Appoints Anika Grant as Chief People Officer 

Ubisoft Appoints Anika Grant as Chief People Officer 

Ubisoft Appoints Anika Grant as Chief People Officer 

Paris, France  April 8, 2021 — Today, Ubisoft announced the appointment of Anika Grant as its new Chief People Officer and member of Ubisoft’s Executive Committee, effective April 8.  

In this role, Anika will oversee all aspects of Ubisoft’s people strategy and drive HR excellence at the company. Reporting directly to Ubisoft’s Co-Founder and CEO Yves Guillemot, Anika will implement innovative and best-in-class strategies to develop talents within Ubisoft. Anika’s responsibilities will cover Ubisoft’s global recruiting, talent management, leadership development, and compensation and benefits, and will contribute to improving the company’s organizational performance. Anika will leverage the company’s strong workplace culture and ensure it is anchored in safety, respect, and wellbeing, enabling every team member to learn, grow and flourish.   

Anika has 19 years of experience leading HR transformation in major, fast-paced, and customer-focused organizations across various sectors. She also brings exceptional knowledge of international HR management, most recently as Global HR Director for Dyson’s Global Markets. Prior to that, Anika held the position of Senior Director HR at Uber where she led a Global HR Business Partner team for Uber's Core Business (covering Rides, Uber Eats and Uber 4 Business). 

Yves Guillemot, Co-Founder and Chief Executive Officer of Ubisoft, said, “I am very happy to welcome Anika Grant as our new Chief People Officer. Her energy, optimism and breadth of experience will be great assets to keep evolving our approach to HR and talent management. Working alongside me, Anika’s mission will consist of aligning all our HR teams with a strong, shared vision, building a robust talent pipeline, and implementing innovative and new ways of working. Anika will also be focusing her leadership efforts on strengthening our global corporate culture, ensuring that all our teams can thrive in an environment that promotes a culture of respect, diversity, inclusion and collective wellbeing.” 

Anika Grant, Ubisoft’s new Chief People Officer, said, “I’m excited to be part of Ubisoft, whose mission is to provide opportunities for enrichment and self-discovery through innovative and original gaming experiences. I am also incredibly proud to partner with the talented, passionate people at Ubisoft to deliver on this mission, and confident that together we will continue making Ubisoft an employer of choice, one that offers its team members exciting challenges, a welcoming and open environment, and the freedom to express their creativity every day.”  

Note to Editors – Anika Grant’s Biography 

An Australian citizen, Anika has served in a diverse range of global leadership roles across Sydney, London, Paris, and Singapore. Most recently, she was Global HR Director at Dyson, where she led an HR team supporting Dyson’s Global Markets, steering the team through the Covid-19 crisis and the transformation of the Company’s operating model. Anika previously held the position of Senior Director HR at Uber, where she led a Global HR Business Partner team for Uber's Core Business, establishing an international HR team within a context of hyper-growth and leading culture change across significant parts of the business. Prior to Uber, Anika was the APAC HR Director at Accenture, where she was responsible for all HR service delivery across eight markets. Anika is currently a Board Advisor at Ecosystm, a digital technology research and advisory firm, and AwanTunai, an Indonesian Fintech enabling financial inclusion. She graduated from UNSW Australia with a BSc (Business Information Technology).  



# # # 

 

Contacts 

   

About Ubisoft 

  

Investor Relations

Jean-Benoît Roquette

SVP Investor Relations

39

Alexandre Enjalbert

Senior Investor Relations Manager

78

Press Relations

Michael Burk

Senior Director of Corporate Public Relations

03

  

Ubisoft is a leading creator, publisher and distributor of interactive entertainment and services, with a rich portfolio of world-renowned brands, including Assassin’s Creed®, Far Cry®, For Honor®, Just Dance®, Watch Dogs®, Tom Clancy’s video game series including Ghost Recon®, Rainbow Six® and The Division®. The teams throughout Ubisoft’s worldwide network of studios and business offices are committed to delivering original and memorable gaming experiences across all popular platforms, including consoles, mobile phones, tablets, and PCs. For the 2019–20 fiscal year, Ubisoft generated net bookings of €1,534 million. To learn more, please visit: . 

© 2021 Ubisoft Entertainment. All Rights Reserved. Ubisoft and the Ubisoft logo are registered trademarks in the US and/or other countries. 

Attachment



EN
08/04/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ubisoft Entertainment SA

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PEGA PEGASYSTEMS INC.
PANW PALO ALTO NETWORKS INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
IMAX IMAX CORPORATION
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
ZG ZILLOW GROUP INC. CLASS A
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
STOK STOKE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
APGE APOGEE THERAPEUTICS INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
LAC. LITHIUM AMERICAS CORP NEW
ORKA ORUKA THERAPEUTICS INC
ZBIO ZENAS BIOPHARMA INC.
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
 PRESS RELEASE

Informations sur les droits de vote et les actions au 31 août 2025

Informations sur les droits de vote et les actions au 31 août 2025    Le 11 septembre 2025 Information relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Information mensuelle au 31 août 2025(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Date Nombre total d’actions composa...

 PRESS RELEASE

Informations sur les droits de vote et les actions au 31 juillet 2025

Informations sur les droits de vote et les actions au 31 juillet 2025 Le 6 août 2025 Information relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Information mensuelle au 31 juillet 2025(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Date Nombre total d’actions composant l...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch